Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 281

1.

Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.

Dragomir A, Côté R, Roy L, Blais L, Lalonde L, Bérard A, Perreault S.

Med Care. 2010 May;48(5):418-25. doi: 10.1097/MLR.0b013e3181d567bd.

PMID:
20393367
2.

Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention.

Kettani FZ, Dragomir A, Côté R, Roy L, Bérard A, Blais L, Lalonde L, Moreau P, Perreault S.

Stroke. 2009 Jan;40(1):213-20. doi: 10.1161/STROKEAHA.108.522193. Epub 2008 Nov 26.

3.

Impact of better adherence to statin agents in the primary prevention of coronary artery disease.

Perreault S, Dragomir A, Blais L, Bérard A, Lalonde L, White M, Pilon D.

Eur J Clin Pharmacol. 2009 Oct;65(10):1013-24. doi: 10.1007/s00228-009-0673-0. Epub 2009 Jun 16.

PMID:
19529927
4.

Adherence level of antihypertensive agents in coronary artery disease.

Perreault S, Dragomir A, Roy L, White M, Blais L, Lalonde L, Bérard A.

Br J Clin Pharmacol. 2010 Jan;69(1):74-84. doi: 10.1111/j.1365-2125.2009.03547.x.

5.

Better adherence to antihypertensive agents and risk reduction of chronic heart failure.

Perreault S, Dragomir A, White M, Lalonde L, Blais L, Bérard A.

J Intern Med. 2009 Aug;266(2):207 - 18.

PMID:
19623691
6.

Persistence with treatment in newly treated middle-aged patients with essential hypertension.

Perreault S, Lamarre D, Blais L, Dragomir A, Berbiche D, Lalonde L, Laurier C, St-Maurice F, Collin J.

Ann Pharmacother. 2005 Sep;39(9):1401-8. Epub 2005 Aug 2.

PMID:
16076920
7.

Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting.

Dragomir A, Côté R, White M, Lalonde L, Blais L, Bérard A, Perreault S.

Value Health. 2010 Jan-Feb;13(1):87-94. doi: 10.1111/j.1524-4733.2009.00583.x. Epub 2009 Aug 20.

8.

Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study.

Chapman RH, Petrilla AA, Benner JS, Schwartz JS, Tang SS.

Drugs Aging. 2008;25(10):885-92.

PMID:
18808213
9.

Effect of statin adherence on cerebrovascular disease in primary prevention.

Perreault S, Ellia L, Dragomir A, Côté R, Blais L, Bérard A, Lalonde L.

Am J Med. 2009 Jul;122(7):647-55. doi: 10.1016/j.amjmed.2009.01.032.

PMID:
19559167
10.

Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan.

Wu PH, Yang CY, Yao ZL, Lin WZ, Wu LW, Chang CC.

Am J Hypertens. 2010 Feb;23(2):155-60. doi: 10.1038/ajh.2009.210. Epub 2009 Nov 19.

PMID:
19927135
11.

Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.

Mazzaglia G, Ambrosioni E, Alacqua M, Filippi A, Sessa E, Immordino V, Borghi C, Brignoli O, Caputi AP, Cricelli C, Mantovani LG.

Circulation. 2009 Oct 20;120(16):1598-605. doi: 10.1161/CIRCULATIONAHA.108.830299. Epub 2009 Oct 5.

12.

The economic implications of treating atherothrombotic disease in Australia, from the government perspective.

Ademi Z, Liew D, Hollingsworth B, Wolfe R, Steg GP, Bhatt DL, Reid CM; REACH Registry Investigators.

Clin Ther. 2010 Jan;32(1):119-32; discussion 106-7. doi: 10.1016/j.clinthera.2010.01.009.

PMID:
20171418
13.

First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.

Sung SK, Lee SG, Lee KS, Kim DS, Kim KH, Kim KY.

Clin Ther. 2009 Jun;31(6):1309-20. doi: 10.1016/j.clinthera.2009.06.011.

PMID:
19695396
14.

[Adherence to antihypertensive and lipid-lowering medications: a problem of public health, not yet resolved].

Grosso G, Raciti T, Marventano S, Romeo I, Mistretta A.

Ann Ig. 2011 Mar-Apr;23(2):173-84. Italian.

PMID:
21770233
15.

Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.

Esposito D, Bagchi AD, Verdier JM, Bencio DS, Kim MS.

Am J Manag Care. 2009 Jul;15(7):437-45.

16.

Antihypertensive medication adherence and subsequent healthcare utilization and costs.

Pittman DG, Tao Z, Chen W, Stettin GD.

Am J Manag Care. 2010 Aug;16(8):568-76.

18.

Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.

Balu S, Simko RJ, Quimbo RM, Cziraky MJ.

Curr Med Res Opin. 2009 Nov;25(11):2765-75. doi: 10.1185/03007990903297741.

PMID:
19785511
19.

Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.

Mazzaglia G, Mantovani LG, Sturkenboom MC, Filippi A, Trifirò G, Cricelli C, Brignoli O, Caputi AP.

J Hypertens. 2005 Nov;23(11):2093-100.

PMID:
16208153
20.
Items per page

Supplemental Content

Write to the Help Desk